Relationship between the As2O3 Induced Expression of NF-κB and Drug Resistance in K562/ADR Cells.

Xiao­hong Zhang(Qiqihar University), Qinghua Lv(Zhejiang Cancer Hospital), Li‐Da Su(Key Laboratory of Guangdong Province), Xiaoying Zhao(Handan College)
Blood
November 16, 2005
10.1182/blood.v106.11.4414.4414
Cited by 7

Related Papers

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2012|396
CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2013|247
Ki-67 is a valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes: evidence from a systematic meta-analysis
|BMC Cancer|2014|146
Up-regulation of gastric cancer cell invasion by Twist is accompanied by N-cadherin and fibronectin expression
|Biochemical and Biophysical Research Communications|2007|141